Role of golimumab, a TNF-alpha inhibitor, in the treatment of the psoriatic arthritis
Melissa A Michelon1, Alice B Gottlieb1,21Tufts University School of Medicine, 2Department of Dermatology, Tufts Medical Center, Boston, MA, USAAbstract: Psoriatic arthritis (PsA) is an inflammatory arthritis that affects many psoriasis patients and can often have a debilitating disease progression....
Main Authors: | Melissa A Michelon, Alice B Gottlieb |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-05-01
|
Series: | Clinical, Cosmetic and Investigational Dermatology |
Online Access: | http://www.dovepress.com/role-of-golimumab-a-tnf-alpha-inhibitor-in-the-treatment-of-the-psoria-a4503 |
Similar Items
-
Golimumab for the treatment of psoriatic arthritis
by: H Yang, et al.
Published: (2011-05-01) -
Golimumab in the treatment of psoriatic arthritis: efficacy and safety
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2015-09-01) -
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
by: M. Rossini, et al.
Published: (2015-03-01) -
Golimumab for Rheumatoid Arthritis
by: Eleftherios Pelechas, et al.
Published: (2019-03-01) -
Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis
by: Sara Rahmati, et al.
Published: (2020-12-01)